The FDA approval was a gimme after the final submission.Not...

The FDA approval was a gimme after the final submission.
Not unexpected so small rise understandable.

Best thing is that it has given seeking apha


http://seekingalpha.com/article/897331-fda-gives-the-ok-in-biggest-news-for-this-medical-device-company-to-date?source=yahoo

and hopefully more analysts the confidence to state the obvious.

Finnally
-someones saying current valuations are not near the mark,
"force analysts to revise their models upwards"
-nearly, nearly getting over the thoratec "thing" and get into the top 10 medical device companies
"not just for Thoratech, but larger device manufacturers like Boston Scientific (BSX)"
- begin to float the idea this company is worth billions (its actually 10's of billions but a billion is a start)
"external defibrillator developed by Cameron Health, which was acquired by Boston Scientific earlier this year for $1.35 billion"

stiil angry about the capital raising.